The challenge of drug-resistant tuberculosis

Area of Science:

• Public Health
• Infectious Diseases
• Epidemiology

Background:

• Tuberculosis (TB) incidence, after decades of decline, is increasing globally.
• Multidrug-resistant tuberculosis (MDR-TB) strains are emerging, posing a significant treatment challenge.
• Disproportionate increases in TB infection are observed in Black and Hispanic populations.

Purpose of the Study:

• To highlight the resurgence of tuberculosis and the challenges posed by drug resistance.
• To emphasize the increased severity and diagnostic difficulties in immunocompromised patients.
• To outline strategies for controlling the current tuberculosis epidemic.

Main Methods:

• Review of clinical trends in tuberculosis incidence and drug resistance.
• Analysis of risk factors and vulnerable populations, including HIV-infected and immunosuppressed patients.
• Assessment of treatment adherence and regimen adequacy contributing to drug resistance.

Main Results:

• Rising tuberculosis incidence and emergence of multidrug-resistant strains.
• Increased disease severity and diagnostic challenges in patients with HIV and those on immunosuppressive therapy.
• Drug resistance linked to inadequate treatment regimens and poor patient compliance.

Conclusions:

• The current tuberculosis epidemic is controllable with a concerted commitment from the public, medical community, government, and industry.
• Physicians must actively prevent TB spread, detect infected individuals, and initiate preventive therapy with isoniazid.
• Prompt diagnosis and adequate, directly supervised, four-drug regimens are crucial for treating active tuberculosis cases.
• Development of convenient combination drug preparations and directly supervised medication programs is needed.